News & Updates
News
NEWS RELEASE: Interim Legislative Health and Human Services Committee Unanimously Endorses Prescription Drug Affordability Act
SANTA FE, NM – Barbara Webber, Executive Director of Health Action New Mexico, provided the following statement following a unanimous vote of the Interim Legislative Health and Human Services Committee today endorsing the Prescritpion Drug Affordability Act. A Prescription Drug Affordability Board (PDAB) would regulate prescription drugs with costs that greatly impact New Mexicans, including high-cost, […]
New Mexico Legislature to take on unaffordable prescription drug prices
SANTA FE, NM – Creating a prescription drug affordability board is among the top recommendations for New Mexico to determine the true cost of prescription drugs and help make medications more affordable for consumers, according to a new bipartisan National Conference of State Legislatures report to be presented tomorrow to the Interim Legislative Health and Human Services Committee.
New Mexico needs to ensure more affordable prescription drugs
Despite massive spending on lobbying and campaign contributions, the big drug companies are slowly losing their stranglehold on state legislatures across the country.
David Mitchell Talks Affordable Prescriptions
The latest @PhRMA false attack on Medicare negotiations is that proposed legislation will limit our access to prescription drugs. It’s important to set the record straight clearly and directly.
NEW REPORT: Drug Companies on the Wrong Side of the Drug Pricing Issue Launch Campaign of Big Lies and Fake Front Groups
As Democrats in Congress work to respond to their constituents and pass reforms that lower the price of prescription drugs for patients, Big Pharma has begun to deploy it’s vast warchest - and a series of well-funded front groups - to mislead, distort
and outright threaten patients in their effort to hold on to their staggering prices and profits.
Fact-Checking Pharma
New ad campaigns financed by the pharmaceutical industry are spreading rumors about direct Medicare negotiation — here's why those rumors are false.
‘We Just Have To All Agree That This Isn’t Working’: Drug-Pricing Reform Faces ‘Pivotal’ Moment On Capitol Hill
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
We can make drugs more affordable for New Mexicans
It is tough to go even a week without seeing another report about pharmaceutical industry profiteering, and it’s time for New Mexicans to fight back.
Colorado looks to lower high prescription drug costs by reviewing prices, setting ceilings
A bill creating a drug affordability board is headed to Governor Jared Polis
Time to make drugs more affordable for New Mexicans
It is tough to go even a week without seeing another report about pharmaceutical industry profiteering, and it’s time for New Mexicans to fight back. In the latest outrage, the New York Times reports the drug manufacturer Biogen will charge $56,000 a year for its new Alzheimer’s drug, Aduhelm.